NasdaqCM - Nasdaq Real Time Price USD
Fennec Pharmaceuticals Inc. (FENC)
5.18
-0.03
(-0.58%)
As of 12:02:59 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | -0.09 | -0.06 | -0.05 | 0.72 |
| Low Estimate | -0.13 | -0.1 | -0.28 | 0.63 |
| High Estimate | -0.05 | -0.01 | 0.15 | 0.77 |
| Year Ago EPS | 0.41 | -0.2 | 0 | -0.05 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 5 |
| Avg. Estimate | 8.18M | 9.35M | 47.86M | 82.13M |
| Low Estimate | 7.57M | 8.41M | 36.27M | 66.51M |
| High Estimate | 8.96M | 10.6M | 62.32M | 120.31M |
| Year Ago Sales | 25.38M | 7.26M | 47.54M | 47.86M |
| Sales Growth (year/est) | -67.76% | 28.80% | 0.67% | 71.63% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.05 | 0.02 | -0.08 | -0.13 |
| EPS Actual | 0.41 | -0.2 | -0.21 | -0.06 |
| Difference | 0.45 | -0.22 | -0.13 | 0.07 |
| Surprise % | 1,011.11% | -1,009.09% | -162.50% | 53.85% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.09 | -0.06 | -0.05 | 0.72 |
| 7 Days Ago | -0.09 | -0.06 | -0.05 | 0.72 |
| 30 Days Ago | -0.11 | -0.08 | -0.16 | 0.56 |
| 60 Days Ago | -0.11 | -0.08 | -0.16 | 0.56 |
| 90 Days Ago | -0.11 | -0.06 | 0.1 | 1.1 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | 2 | -- | -- |
| Up Last 30 Days | 2 | 2 | 2 | 2 |
| Down Last 7 Days | 1 | 1 | -- | 1 |
| Down Last 30 Days | 1 | 1 | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| FENC | -120.73% | 70.00% | 0.00% | 1,466.67% |
| S&P 500 | 7.01% | 4.85% | 8.55% | 14.15% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/11/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/17/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 8/22/2024 |
| Maintains | Craig-Hallum: Buy to Buy | 8/14/2024 |
| Maintains | Craig-Hallum: Buy to Buy | 5/15/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 5/15/2024 |
Related Tickers
SCPH scPharmaceuticals Inc.
2.5600
0.00%
ZHCLF Zenith Capital Corp.
0.0001
0.00%
WHWK Whitehawk Therapeutics, Inc.
1.5500
0.00%
KZR Kezar Life Sciences, Inc.
4.3700
+5.37%
TSBX Turnstone Biologics Corp.
0.3311
+2.19%
IGMS IGM Biosciences, Inc.
1.4450
+12.89%
BRNS Barinthus Biotherapeutics plc
0.7285
-0.21%
IMUC EOM Pharmaceuticals Holdings, Inc.
0.1390
0.00%
NXTC NextCure, Inc.
0.3901
+3.61%
EPRX Eupraxia Pharmaceuticals Inc.
3.7000
+6.17%